Merck & Co Inc (NYSE:MRK)
| 103.00 Delayed Data As of 4:00pm ET |  -1.30 / -1.25%Today’s Change | 86.02 Today|||52-Week Range 119.65 | -7.17% Year-to-Date |
Latest MRK News | Press Releases
Today’s Trading
| Previous close | 104.30 |
| Today’s open | 104.36 |
| Day’s range | 102.72 - 104.57 |
| Volume | 7,232,722 |
| Average volume (3 months) | 7,217,713 |
| Market cap | $269.8B |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +11.18% |
| Earnings growth (this year) | -58.25% |
| Earnings growth (next 5 years) | +7.72% |
| Revenue growth (last year) | +19.56% |
| P/E ratio | 84.4 |
| Price/Sales | 4.82 |
| Price/Book | 5.87 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -3.15 | -2.07% |
| NONOFNovo Nordisk | -0.58 | -0.63% |
| NVSNovartis | -0.45 | -0.44% |
| AZNAstraZeneca | +0.30 | +0.44% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | October 26, 2023 |
| EPS forecast (this quarter) | $1.96 |
| Annual revenue (last year) | $58.5B |
| Annual profit (last year) | $14.5B |
| Net profit margin | 24.83% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Kenilworth, New Jersey |
Forecasts
